# FDA 483 - Andrew C. Siesennop, MD - August 04, 2023

Source: https://www.keypedia.com/records/483/andrew-c-siesennop-md/507aefc9-8f3c-4b92-88d6-1fc83d8052e3

> FDA 483 for Andrew C. Siesennop, MD on August 04, 2023. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Andrew C. Siesennop, MD
- Inspection Date: 2023-08-04
- Product Type: drugs
- Office Name: Division of Northeast Imports 
- Summary: An FDA inspection of Andrew C. Siesennop, MD in Boston, MA, revealed a significant issue with the conduct of an investigational study. The firm failed to follow its investigational plan, resulting in three subjects being incorrectly dosed with the study drug. This indicates a deviation from proper clinical trial procedures.

## Related Officers

- [issuing_officer](https://www.keypedia.com/people/kent-a-conforti/8d3d3e82-cd97-420e-8840-df92d6eeba09)

Company: https://www.keypedia.com/companies/andrew-c-siesennop-md/5b4b5f35-f383-4ba9-bf93-24af90d7b13f

Office: https://www.keypedia.com/offices/division-of-northeast-imports/b20599cf-9797-41fd-947f-6589ef596a94